. . . . . . . "[Our data provide first evidence that modulation of the MDM2/p53 pathway may be therapeutically useful to improve the apoptotic response of KIT-inhibitory drugs in the treatment of na\uFFFDve GIST, with p53 mutation status being a predictive factor of response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:09+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .